republic-os/legislation/us/states/de/150/hb-141.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE MEDICAL MARIJUANA ACT.	New daily persistent headache (NDPH) is a rare headache disorder characterized by daily and unremitting headaches that can last up to 3 days. Headache onset is abrupt and the throbbing, pressure-like pain is usually on both sides of the head. In order to be diagnosed with this syndrome, a patient has chronic daily headaches that are present more than 15 days a month for more than 3 months. The age of onset ranges from 6 to greater than 70 years old. It is found to be more common in females in both the adult and pediatric populations. Currently, there is no specific treatment for NDPH. Instead, most are treated similarly to migraines with prescriptions to opiates or narcotics such as gabapentin. In order to avoid the development of medication overuse or addiction, however, physicians do not advise patients to use pain relievers for more than 9 days a month even though the pain persists for many days more than that. Moreover, NDPH is an intractable headache disorder that is unresponsive to standard headache therapies.	us/states/de	Delaware General Assembly	150	HB 141	Delaware HB 141 (150)	bill		enacted	David B. McBride Ernesto B Lopez Melissa Minor-Brown Peter C. Schwartzkopf	2	8	2	2019-05-06	2019-06-13	openstates	ocd-bill/6a1d04c9-b125-414f-b5b8-da6644a1a91b	https://legis.delaware.gov/BillDetail?LegislationId=47419	55cee8935c54c21c91b6e3d1c0c07bb6b8a8f04eb09b823b3dc6126996e70791	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-de

Delaware HB 141 (150) — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE MEDICAL MARIJUANA ACT.

New daily persistent headache (NDPH) is a rare headache disorder characterized by daily and unremitting headaches that can last up to 3 days. Headache onset is abrupt and the throbbing, pressure-like pain is usually on both sides of the head. In order to be diagnosed with this syndrome, a patient has chronic daily headaches that are present more than 15 days a month for more than 3 months. The age of onset ranges from 6 to greater than 70 years old. It is found to be more common in females in both the adult and pediatric populations. Currently, there is no specific treatment for NDPH. Instead, most are treated similarly to migraines with prescriptions to opiates or narcotics such as gabapentin. In order to avoid the development of medication overuse or addiction, however, physicians do not advise patients to use pain relievers for more than 9 days a month even though the pain persists for many days more than that. Moreover, NDPH is an intractable headache disorder that is unresponsive to standard headache therapies.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Bill Text (committee substitute) — source
2. HA 1 to HB 141 (committee substitute) — source

Votes

• SM — 20–0 (pass) · upper
• SM — 41–0 (pass) · lower

Sponsors

• David B. McBride — primary (person)
• Ernesto B Lopez — primary (person)
• Melissa Minor-Brown — primary (person)
• Peter C. Schwartzkopf — primary (person)
• Bryan W. Shupe — cosponsor (person)
• Charles S Postles Jr. — cosponsor (person)
• Daniel B. Short — cosponsor (person)
• Earl G. Jaques Jr. — cosponsor (person)
• Gerald L. Brady — cosponsor (person)
• Jeffrey N. Spiegelman — cosponsor (person)
• John A. Kowalko — cosponsor (person)
• Kendra Johnson — cosponsor (person)
• Kimberly Williams — cosponsor (person)
• Krista Griffith — cosponsor (person)
• Michael Ramone — cosponsor (person)
• Nnamdi O. Chukwuocha — cosponsor (person)
• Paul S. Baumbach — cosponsor (person)
• Raymond Seigfried — cosponsor (person)
• Stephanie T. Bolden — cosponsor (person)
• William J. Carson — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2019-05-06 Introduced and Assigned to Health & Human Development Committee in House introduction, referral-committee
• 2019-05-15 Reported Out of Committee (Health & Human Development) in House with 3 Favorable, 4 On Its Merits committee-passage-favorable, committee-passage
• 2019-05-16 Amendment HA 1 to HB 141 - Introduced and Placed With Bill amendment-introduction
• 2019-05-16 Amendment HA 1 to HB 141 - Passed In House by Voice Vote amendment-passage
• 2019-05-16 Passed By House. Votes: 41 YES passage
• 2019-06-05 Reported Out of Committee (Health & Social Services) in Senate with 2 Favorable, 3 On Its Merits committee-passage-favorable, committee-passage
• 2019-06-13 Passed By Senate. Votes: 20 YES 1 ABSENT passage
• 2019-06-13 Signed by Governor executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/6a1d04c9-b125-414f-b5b8-da6644a1a91b. Confidence: reported (aggregated from official Delaware legislature records).